Aachen papers per year

Papers 116

Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical Practice Guideline for diagnosis, treatment, and follow‐up
2025 HemaSphere article Medicine Lymphoma Diagnosis and Treatment Open access

Francesco d’Amore, Massimo Federico, Laurence de Leval, Fredrik Ellin, Olivier Hermine, Won Seog Kim, +6 more

3

citations
S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
2023 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Hélène F.E. Gleitz, Inge Snoeren, Stijn N. R. Fuchs, James Shiniti Nagai, Aurélien J. F. Dugourd, Charlotte Boys, +10 more

2

citations
P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA
2022 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Frank Stegelmann, Ekaterina Jahn, Steffen Koschmieder, Florian Heinrich Heidel, Andreas Hochhaus, H. Hebart, +18 more

2

citations
Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
2023 HemaSphere article Medicine Hematopoietic Stem Cell Transplantation Open access

Margherita Vieri, Benjamin Rolles, Maria Crocioni, Mirle Schemionek, Susanne Isfort, Jens Panse, +2 more

2

citations
P831: PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL
2022 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Alexander Röth, Jens Panse, B. Gentile, Muriel Buri, H. Patel, Zsolt Nagy

2

citations
PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
2023 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

Andreas Hochhaus, Susanne Saußele, François‐Xavier Mahon, Virginia Pilipovic, Yifan Zhang, Peter Schuld, +1 more

2

citations
S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
2023 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

Marius Bill, Leo Ruhnke, Sven Zukunft, Silvia Schäfer, Jan‐Niklas Eckardt, Sebastian Stasik, +42 more

2

citations
S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
2023 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +28 more

2

citations
P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL
2023 HemaSphere article Immunology and Microbiology Mast cells and histamine Open access

Jason R. Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Sigurd Broesby‐Olsen, +34 more

2

citations
Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee
2025 HemaSphere article Medicine CAR-T cell therapy research Open access

Nick van Sinderen, Julie Dolva, Caterina Riillo, Raquel Espada, Christof Scheid, Suzanne van Dorp, +16 more

2

citations
Quality of vitamin K antagonist treatment during the last year of life
2025 HemaSphere article Medicine Atrial Fibrillation Management and Outcomes Open access

Chantal Visser, Eva K Kempers, Jamilla Goedgebuur, Denise Abbel, Sarah J Aldridge, Adrian Edwards, +17 more

2

citations
P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCOMES OF LENALIDOMIDE REFRACTORY VS. LENALIDOMIDE EXPOSED RRMM PATIENTS IN THE HONEUR FEDERATED DATA NETWORK
2023 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Ivan Špıčka, Ido Lapidot, Maximilian Merz, Jakub Radocha, Martin Štork, Tomáš Jelı́nek, +12 more

2

citations
P1209: INCIDENCE, TREATMENT AND OUTCOME OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS
2022 HemaSphere article Medicine Breast Implant and Reconstruction Open access

Frederik O. Meeuwes, Mirian Brink, Marjolein van der Poel, Marie José Kersten, M. J. Wondergem, Pim G. N. J. Mutsaers, +9 more

2

citations
P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).
2022 HemaSphere article Medicine Platelet Disorders and Treatments Open access

Arija G. Jansen, Vickie McDonald, A. C. Newland, M. Morgan, S. Visser-Peereboom, Koo Wilson, +4 more

2

citations
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
2021 HemaSphere article Immunology and Microbiology Immunotherapy and Immune Responses Open access

Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García‐Cadenas, Fred Falkenburg, Natacha Bolaños, +10 more

2

citations
PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS
2023 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

Susanne Isfort, Carlo B Gambacorti-Passerini, Tim H. Brümmendorf, Benjamin D. Smith, Simon Purcell, Huadong Zhao, +2 more

1

citations
Application of machine learning in the diagnostic work‐up of telomere biology disorders
2026 HemaSphere article Medicine Telomeres, Telomerase, and Senescence Open access

Erika Massaccesi, Luca Arcuri, Giacomo Cavalca, Fabian Beier, Lucia Vankann, Michela Lupia, +23 more

1

citations
P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO EVALUATE IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS REFRACTORY TO JANUS KINASE INHIBITOR
2022 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +11 more

1

citations
P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT
2022 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Romain Tilmont, Ibrahim Yakoub‐Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Nicolaas PM Schaap, +18 more

1

citations
P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
2023 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Kathrin Olschok, Bianca Altenburg, Marcelo A. S. Toledo, Angela Maurer, Anne Abels, Fabian Beier, +6 more

1

citations

Most active Aachen authors

Tim H. Brümmendorf 16,145 citations overall
18 papers
Jens Panse 10,288 citations overall
14 papers
Steffen Koschmieder 11,677 citations overall
13 papers
Joost S.P. Vermaat 3,482 citations overall
10 papers
Fabian Beier 3,900 citations overall
9 papers
Susanne Isfort 2,466 citations overall
8 papers
Jacques J. M. van Dongen 55,067 citations overall
5 papers
Martina Margrit Crysandt 2,348 citations overall
5 papers
Ivan G. Costa 12,219 citations overall
4 papers
Edgar Jost 3,752 citations overall
4 papers
Deniz Gezer 1,428 citations overall
4 papers
Margherita Vieri 507 citations overall
4 papers
Rafael Kramann 16,535 citations overall
3 papers
James Shiniti Nagai 2,988 citations overall
3 papers
Nicolas Chatain 1,606 citations overall
3 papers

HemaSphere ▲ Sign in to save

Aachen papers per year

Papers 116

Most active Aachen authors

HemaSphere Sign in to save